Back close

Mutation of the MYL3 gene in a patient with mid-ventricular obstructive hypertrophic cardiomyopathy

Publication Type : Journal Article

Source : BMJ Case Reports CP

Url : https://casereports.bmj.com/content/15/3/e244573.abstract

Campus : Kochi

School : School of Medicine

Year : 2022

Abstract : In this study, we discuss a female patient referred to cardiology with left ventricular hypertrophy at mid-ventricular segments resulting in a mid-cavitary obstruction and a left ventricular apical aneurysm. The patient had normal epicardial coronary arteries, but presented with recurrent cerebrovascular events. The patient had a positive family history for sudden cardiac death. Cardiac MRI detected positive features of left ventricular mid-cavity obstruction, left ventricular apical aneurysm and delayed gadolinium enhancement, with Holter monitoring assessment displaying segments of non-sustained ventricular tachycardia. Genetic analysis detected an myosin light chain 3 (MYL3) gene mutation. The patient will be referred to receive an implantable cardioverter defibrillator. The MYL3 gene mutation is a rare variant in patients with familial hypertrophic cardiomyopathy. To our knowledge, the presence of a left ventricular apical aneurysm has not been previously reported in literature concerning the MYL3 gene mutation. The presence of this abnormality further increases the risk of sudden cardiac death.

Cite this Research Publication : Akash Mavilakandy, Hisham Ahamed, Mutation of the MYL3 gene in a patient with mid-ventricular obstructive hypertrophic cardiomyopathy, BMJ Case Reports CP,2022.

Admissions Apply Now